{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:23:18Z","timestamp":1769721798127,"version":"3.49.0"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Kerion celsi represents the inflammatory extreme of tinea capitis, as a delayed hypersensitivity reaction to the causative dermatophyte. Data regarding prevalence, trends in pathogens, and risk factors for scarring are limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The main objective of the study is to assess clinical and epidemiologic features of children with kerion celsi and risk factors for scarring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We reviewed medical records of pediatric patients with kerion celsi treated between January 2006 and July 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 80 patients, the prevalence of permanent alopecia was 27.5%. Patients with remaining alopecia presented to our clinic at a mean 1.3\u00a0months earlier than those with complete response to treatment (2.2\u00a0\u00b1\u00a02.1 and 3.4\u00a0\u00b1\u00a04.8, respectively; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a0.05). Patients of Ethiopian ethnicity were more represented than in the general population; however, scarring was observed in only 11% (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.08). Outcomes did not differ by pathogen, antifungal treatment prescribed, duration of treatment, or the use of prednisone or antibiotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Scarring alopecia is a common complication of kerion celsi. Host innate immune response, pathogen virulence, and treatment timeline should be considered as possible variables affecting risk of scarring in the future studies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/pde.14916","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T06:13:33Z","timestamp":1642140813000},"page":"215-219","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epidemiologic features and risk of scarring in pediatric patients with kerion celsi"],"prefix":"10.1111","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8117-3656","authenticated-orcid":false,"given":"Rivka","family":"Friedland","sequence":"first","affiliation":[{"name":"Pediatric Dermatology Unit Schneider Children's Medical Center of Israel  Petach Tikva Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareed","family":"Sabbah","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit Schneider Children's Medical Center of Israel  Petach Tikva Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiran","family":"Reiss\u2010Huss","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit Schneider Children's Medical Center of Israel  Petach Tikva Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6390-1269","authenticated-orcid":false,"given":"Dan","family":"Ben Amitai","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit Schneider Children's Medical Center of Israel  Petach Tikva Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13196"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12020"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13423"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00436787"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30105-1"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-008-9108-1"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13257"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2012.05.003"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01645.x"},{"issue":"1","key":"e_1_2_10_11_1","first-page":"14","article-title":"A new paradigm in the treatment of kerions: treat the inflammation","volume":"10","author":"Dolder SE","year":"2012","journal-title":"Skinmed"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1994.tb00079.x"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-280X.1999.00199.x"},{"key":"e_1_2_10_14_1","unstructured":"The Ethiopian Population in Israel.Central Bureau of statistics. Accessed December 20 2020.https:\/\/www.cbs.gov.il\/en\/mediarelease\/Pages\/2020\/The\u2010Ethiopian\u2010Population\u2010in\u2010Israel.aspx"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1998.tb00319.x"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200607050-00007"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15668"},{"issue":"1","key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2340\/000155557374","article-title":"Severe flares of acne following isotretinoin: large closed comedones (macrocomedones) are a risk factor","volume":"73","author":"Bottomley WW","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02449.x"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81749-4"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.14916","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/pde.14916","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.14916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T18:43:16Z","timestamp":1692816196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.14916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1111\/pde.14916"],"URL":"https:\/\/doi.org\/10.1111\/pde.14916","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"2022-01-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}